Provided by Tiger Trade Technology Pte. Ltd.

Kalvista Pharmaceuticals Inc

19.33
+0.38002.01%
Post-market: 19.330.00000.00%19:50 EDT
Volume:2.06M
Turnover:39.99M
Market Cap:990.13M
PE:-6.34
High:19.95
Open:19.14
Low:18.82
Close:18.95
52wk High:19.95
52wk Low:9.24
Shares:51.22M
Float Shares:27.92M
Volume Ratio:1.51
T/O Rate:7.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0497
EPS(LYR):-3.0497
ROE:-190.18%
ROA:-60.98%
PB:-365.23
PE(LYR):-6.34

Loading ...

Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Correspondence

Form CORRESP - Correspondence
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Major Issues Report

Form 8-K - Current report